ALQGC Quantum Genomics Société Anonyme

0.0793USD0.0721 EUR · EPA0.00%Mkt Cap: 5.52M USDP/E: —

Quantum Genomics Société Anonyme is in the process of liquidation of its remaining assets. Previously, the company was engaged in the development of drugs to treat cardiovascular diseases. Quantum Genomics Société Anonym…

Institutional holders1 on file

Key Statistics

Company
Market Cap5.52M USD
Enterprise Value8.09M USD
Revenue (TTM)11 USD
Gross Profit-1.26M USD
Net Income (TTM)-9.77M USD
Revenue/Share0.00 USD
Last Price0.0793 USD
Fiscal Year EndDec 2024
MR QuarterDec 2024
Employees1
CountryFR
SectorHealthcare
IndustryBiotechnology
ISINFR0011648971
Valuation
P/E (Trailing)—
P/E (Forward)-0.19
PEG—
EV/EBITDA-5.00
EV/Revenue735674.30
P/S502608.70
P/B-2.06
EPS (TTM)-0.10 USD
EPS (Forward)-0.41 USD
52W Range
—
52W High0.0793 USD
52W Low0.0793 USD
Profitability
Gross Margin0.00%
Oper. Margin-14728340.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE362.09%
ROA-2507.44%
ROIC—
ROCE-806.14%
Growth
Revenue Growth-83.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-22.22M USD
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt2.57M USD
Net Debt/EBITDA-1.59
Net Debt/FCF—
Balance Sheet
Debt/Equity-1.07
Current Ratio0.37
Quick Ratio0.34
Book Value/Sh-0.04 USD
Cash/Share0.0044 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:18
Split DateDec 13, 2013
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.69.71M
Float34.56M
Insiders36.09%
Institutions5.80%
Technical
SMA 500.0793 (-0.0%)
SMA 2000.0793 (-0.0%)
Beta-0.19
S&P 52W Chg8.68%
Avg Vol (30d)0
Avg Vol (10d)0
Technical Indicators
RSI (14)—
MACD0.0000
MACD Signal0.0000
MACD Hist.+0.0000
BB Upper0.0793 USD
BB Middle0.0793 USD
BB Lower0.0793 USD
BB Width0.00%
ATR (14)0.0000 USD
Vol Ratio (20d)—

About Quantum Genomics (EPA: ALQGC)

›

Quantum Genomics (EPA: ALQGC) is listed on Euronext Paris, where its shares trade in EUR. It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 1 employees.

The shares were at 0.0721 EUR on 19 November 2026, roughly unchanged over 52 weeks. Its 52-week range is 0.0721 EUR to 0.0721 EUR, and it trades at the top of that range.

Its market capitalisation is 5.03M EUR.

Quantum Genomics reports return on equity of 362.1% and revenue down 83.3% year over year.

Its debt exceeds its cash by 2.34M EUR. Its Piotroski F-score is 0 out of 9, a weak reading of its financial health.